The conference includes essential topics on Glycobiology, Glycans in Drug Design, Glyco Bioinformatics, Glyco Proteomics, Glyco Immunology, Glyco Biomarkers, Genomics and Metabolomics, Glycobiology and Biotechnology, Glycans in Diseases and Therapeutics, Glycans in Genetic Disorders, Structural Biology, Glycobiology in Personalized Medicine, Glycobiology in vaccine development and many more.

Glycobiology is the study of the structure, biosynthesis, and biology of saccharides (sugar chains or glycans) that are widely distributed in nature. Sugars or saccharides are essential components of all living things and aspects of the various roles they play in biology are researched in various medical, biochemical and biotechnological fields. Global glycobiology market was valued at $512.38 million in 2014 and poised to grow at a CAGR of 12.62% between 2012 and 2019, to reach $928.11 million in 2019. The rapid increase in research and development expenditure by pharmaceutical and biotech companies, and increased funding in proteomics and glycobiology research will be the two most important growth drivers for this market in the forecast period (2012–2019).

Glycobiology conference focuses on the current research and developments in various areas of glycobiology and its related fields. The meeting engrossed a vicinity of latest discussions on novel subjects like 3-D structure determination, drug sequencing, computational approaches in glyco biology, signalling biology, glyco-biology databases, molecular modelling and simulation, drug designing, frontiers in glyco biology and recent advances in glyco biology. The three days event implanted a firm relation of upcoming strategies in the field of glycobiology with the scientific fraternity. The conceptual and applicable knowledge shared will also foster organizational collaborations to nurture scientific accelerations.